Skip to main content

Table 4 summary of studies showing the predictive performance of radiomics signature, clinical-radiological and the combined models

From: The application of texture quantification in hepatocellular carcinoma using CT and MRI: a review of perspectives and challenges

Study

Objectives

No. of subjects

The area under the ROC curve

Sensitivity

Specificity

Best model

RS

CM

COM

RS

CM

COM

RS

CM

COM

Ma et al. [56]

Preoperative prediction of MVI

157 (T:110, V: 47)

0.793

0.761

0.801

0.656

0.944

0.889

0.944

0.655

0.759

COM

Yang et al. [41]

Prediction of MVI

208 (T: 146, V: 62)

0.837

0.759

0.861

0.842

0.737

0.895

0.744

0.674

0.814

COM

Xu et al. [29]

Prediction of MVI and survival

495 (T:350, V:145)

0.806

N/A

0.889

0.755

0.653

0.898

0.719

0.760

0.792

COM

Zhang et al. [57]

Prediction of MVI

267 (T:194, V:73)

0.820

0.721

0.858

0.692

0.269

0.808

0.809

0.936

0.861

COM

Zhu et al. [58]

Prediction of MVI

142 (T:99, V:43)

0.773

N/A

0.794

0.750

N/A

0.812

0.815

N/A

0.852

COM

Zhang et al. [59]

Prediction of early recurrence

155 (T:108, V:47)

0.728

0.814

0.841

0.696

0.783

0.913

0.708

0.833

0.750

COM

Zhou et al. [60]

Prediction of early recurrence

215

0.817

0.781

0.708

0.794

0.784

0.824

0.699

0.619

0.708

COM

  1. T training cohort, V validation cohort, N/A not available, ROC receiver operating characteristic curve, RS Radiomics signature, CM Clinical model, COM Combined model